1Fijin R, Lenderink AW, Eqberts AC, et al. Assessment of indicators for hospital drug formulary non - adherence [ J]. Eur J Clin Pharmacol, 2001,57(9) :677 -684.
2Bielory L, USP Model Guidelines Expert Committee. United States pharmacopeia development of the Medicare model formulary guidelines [J]. Am J Geriatr Cardiol, 2005, 14(6) :301.
3Lehunann DF, Guharoy, Page N, et al. Formulary management as a tool to improve medication use and gain physician support [ J ]. Am J Health Syst Pharm, 2007, 64(5) :464.
4Smetana GW, Davis RB, Phillips RS. Factors that influence patient response to requests to change to a unified restrictive formulary[ J]. J Gen Intern Meal, 2004, 19(12) :1212.
5Olson BM. Approaches to pharmacy benefit management and the impact of consumer cost sharing[ J]. Clin Ther, 2003, 25 (1) :250.
6Shalansky S J, Virk R, Ackman M, et al. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process[J]. Can J Cardiol, 2003, 19(2) :173.
7Hasle - Pham E, Aenould B, Spath HM, et al. Role of clinical, pa- tientreported outcome and medico -economic studies in the public hospital drug formulary decision - making process : results of a Europe- an survey[J]. Health Policy, 2005, 71(2) :205.
8Goldselunid A, Jacknowitz AI, Menczel E. The formulary of a large health maintenance organization in Israel [ J ]. Am J Health Syst Pharm, 2001,58(5) :420.
9Bonati M, Pandolfini C. Children need international formulary to guarantee rational use of drugs[J]. BMJ, 2004, 328(24) :227.
10Hakansson A, Andersson H, Cars H, et al. Prescribing, prescription costs and adherence to formulary committee recommendations: long - term differences between physicians in public and private care[J]. Eur J Clin Pharmacol, 2001,57( 1 ) :65.
